Annual ROE
333.04%
+209.47%+169.52%
December 31, 2021
Summary
- As of February 10, 2025, IDRA annual return on equity is 333.04%, with the most recent change of +209.47% (+169.52%) on December 31, 2021.
- During the last 3 years, IDRA annual ROE has risen by +402.80% (+577.41%).
Performance
IDRA ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly ROE
-64.14%
+2.35%+3.53%
September 30, 2022
Summary
- As of February 10, 2025, IDRA quarterly return on equity is -64.14%, with the most recent change of +2.35% (+3.53%) on September 30, 2022.
- Over the past year, IDRA quarterly ROE has dropped by -530.72% (-113.75%).
Performance
IDRA Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
IDRA ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +169.5% | -113.8% |
| 3 y3 years | +577.4% | +21.0% |
| 5 y5 years | +632.6% | +2.9% |
IDRA ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | at low | -106.7% | +3.7% |
| 5 y | 5-year | at high | -164.2% | -106.7% | +588.5% |
| alltime | all time | -97.9% | -328.4% | -100.9% | >+9999.0% |
Idera Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -64.14%(-3.5%) |
| Jun 2022 | - | -66.49%(+2.6%) |
| Mar 2022 | - | -64.83%(-106.8%) |
| Dec 2021 | 333.04%(+169.5%) | 955.64%(+104.8%) |
| Sep 2021 | - | 466.58%(-565.4%) |
| Jun 2021 | - | -100.25%(-532.1%) |
| Mar 2021 | - | 23.20%(-92.7%) |
| Dec 2020 | 123.57%(-157.8%) | 318.61%(-17.3%) |
| Sep 2020 | - | 385.38%(-187.3%) |
| Jun 2020 | - | -441.59%(+212.0%) |
| Mar 2020 | - | -141.55%(-2.9%) |
| Dec 2019 | -213.97%(+206.7%) | -145.76%(+79.6%) |
| Sep 2019 | - | -81.16%(+15.7%) |
| Jun 2019 | - | -70.12%(+4.6%) |
| Mar 2019 | - | -67.06%(-3.6%) |
| Dec 2018 | -69.76%(+11.6%) | -69.55%(-4.9%) |
| Sep 2018 | - | -73.10%(-4.5%) |
| Jun 2018 | - | -76.51%(-6.6%) |
| Mar 2018 | - | -81.88%(+8.8%) |
| Dec 2017 | -62.53%(+52.3%) | -75.29%(+14.0%) |
| Sep 2017 | - | -66.04%(+3.1%) |
| Jun 2017 | - | -64.07%(+19.0%) |
| Mar 2017 | - | -53.86%(+4.0%) |
| Dec 2016 | -41.07%(-46.3%) | -51.80%(-27.2%) |
| Sep 2016 | - | -71.14%(+18.2%) |
| Jun 2016 | - | -60.20%(+14.4%) |
| Mar 2016 | - | -52.61%(-5.6%) |
| Dec 2015 | -76.47%(-35.8%) | -55.76%(-8.2%) |
| Sep 2015 | - | -60.74%(-5.8%) |
| Jun 2015 | - | -64.47%(-2.1%) |
| Mar 2015 | - | -65.87%(-22.2%) |
| Dec 2014 | -119.15%(-39.6%) | -84.65%(+8.8%) |
| Sep 2014 | - | -77.77%(-7.8%) |
| Jun 2014 | - | -84.33%(-24.3%) |
| Mar 2014 | - | -111.38%(-50.4%) |
| Dec 2013 | -197.41%(-53.7%) | -224.43%(-52.4%) |
| Sep 2013 | - | -471.98%(+56.2%) |
| Jun 2013 | - | -302.20%(-57.3%) |
| Mar 2013 | - | -708.12%(+5.9%) |
| Dec 2012 | -426.18%(+304.4%) | -668.43%(+120.9%) |
| Sep 2012 | - | -302.61%(+63.2%) |
| Jun 2012 | - | -185.38%(+28.7%) |
| Mar 2012 | - | -144.05%(+33.5%) |
| Dec 2011 | -105.38%(+94.2%) | -107.88%(+19.6%) |
| Sep 2011 | - | -90.21%(+11.9%) |
| Jun 2011 | - | -80.60%(+12.0%) |
| Mar 2011 | - | -71.95%(+32.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2010 | -54.26%(-298.7%) | -54.41%(+117.6%) |
| Sep 2010 | - | -25.00%(+127.7%) |
| Jun 2010 | - | -10.98%(-154.1%) |
| Mar 2010 | - | 20.30%(-27.9%) |
| Dec 2009 | 27.31%(+170.4%) | 28.17%(+72.4%) |
| Sep 2009 | - | 16.34%(-40.4%) |
| Jun 2009 | - | 27.42%(+50.4%) |
| Mar 2009 | - | 18.23%(+97.3%) |
| Dec 2008 | 10.10%(-107.6%) | 9.24%(-134.4%) |
| Sep 2008 | - | -26.85%(-64.9%) |
| Jun 2008 | - | -76.51%(-32.8%) |
| Mar 2008 | - | -113.82%(+0.2%) |
| Dec 2007 | -132.37%(-52.3%) | -113.58%(-14.3%) |
| Sep 2007 | - | -132.55%(-23.5%) |
| Jun 2007 | - | -173.38%(-27.1%) |
| Mar 2007 | - | -237.96%(-51.3%) |
| Dec 2006 | -277.70%(+26.0%) | -488.32%(-49.4%) |
| Sep 2006 | - | -964.73%(+84.1%) |
| Jun 2006 | - | -523.97%(+74.2%) |
| Mar 2006 | - | -300.82%(+39.6%) |
| Dec 2005 | -220.46%(+101.6%) | -215.54%(+63.0%) |
| Sep 2005 | - | -132.21%(+14.5%) |
| Jun 2005 | - | -115.50%(+6.1%) |
| Mar 2005 | - | -108.86%(+5.3%) |
| Dec 2004 | -109.36%(-11.2%) | -103.39%(-7.0%) |
| Sep 2004 | - | -111.18%(-15.0%) |
| Jun 2004 | - | -130.77%(-16.8%) |
| Mar 2004 | - | -157.21%(+3.3%) |
| Dec 2003 | -123.12%(-163.1%) | -152.21%(+25.3%) |
| Sep 2003 | - | -121.51%(-221.9%) |
| Jun 2003 | - | 99.72%(-29.1%) |
| Mar 2003 | - | 140.64%(-41.0%) |
| Dec 2002 | 195.10%(-98.8%) | 238.45%(-46.7%) |
| Sep 2002 | - | 447.64%(-102.2%) |
| Jun 2002 | - | -20.02 K%(+3963.9%) |
| Mar 2002 | - | -492.53%(-107.3%) |
| Dec 2001 | 16.02 K%(>+9900.0%) | 6772.19%(+3495.7%) |
| Sep 2001 | - | 188.34%(-619.6%) |
| Jun 2001 | - | -36.25%(-159.7%) |
| Mar 2001 | - | 60.77%(+73.1%) |
| Dec 2000 | 38.81%(-77.5%) | 35.11%(+102.9%) |
| Sep 2000 | - | 17.30%(-67.4%) |
| Jun 2000 | - | 53.01%(+66.7%) |
| Mar 2000 | - | 31.80% |
| Dec 1999 | 172.18%(-122.6%) | - |
| Dec 1998 | -760.57%(-604.2%) | - |
| Dec 1997 | 150.84%(-173.6%) | - |
| Dec 1996 | -205.00% | - |
FAQ
- What is Idera Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals annual ROE year-on-year change?
- What is Idera Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Idera Pharmaceuticals?
- What is Idera Pharmaceuticals quarterly ROE year-on-year change?
What is Idera Pharmaceuticals annual return on equity?
The current annual ROE of IDRA is 333.04%
What is the all time high annual ROE for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high annual return on equity is 16.02 K%
What is Idera Pharmaceuticals annual ROE year-on-year change?
Over the past year, IDRA annual return on equity has changed by +209.47% (+169.52%)
What is Idera Pharmaceuticals quarterly return on equity?
The current quarterly ROE of IDRA is -64.14%
What is the all time high quarterly ROE for Idera Pharmaceuticals?
Idera Pharmaceuticals all-time high quarterly return on equity is 6772.19%
What is Idera Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, IDRA quarterly return on equity has changed by -530.72% (-113.75%)